Latest News
This week, the second-year results of an important clinical trial on age-related macular degeneration (AMD), known as the Comparison of AMD Treatments Trials (or CATT), were published in the journal Ophthalmology.
Computer-animated 3D visuals providing an internal look at the eye's anatomy are now available on the American Health Assistance Foundation website, www.ahaf.org. Visitors can watch 127 videos-in English and Spanish-that demonstrate a range of topics including the origins, progression, diagnosis, and treatment of eye diseases.
“In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease,” said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation, a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.
The American Health Assistance Foundation, a nonprofit organization that supports research and public information through its Alzheimer's Disease Research program, welcomes today's announcement by Health and Human Services Secretary Kathleen Sebelius that the Obama Administration will dedicate more resources, in 2012 and beyond, to the fight against Alzheimer's disease.
Two different research groups have independently made the same important discoveries on how Alzheimer's disease spreads in the brain, according to a February 2 New York Times story.
A scientific research bill announced on Capitol Hill today represents a major step forward in the national goal to end Alzheimer's disease, says the American Health Assistance Foundation, a nonprofit organization whose Alzheimer's Disease Research program funds research worldwide.
The American Health Assistance Foundation, a nonprofit organization that funds innovative, early-stage research through its Alzheimer's Disease Research (ADR) program, welcomed the release of a draft framework to stop the disease over the next decade.
"The 21st Century Brain Trust™," a coalition of four nonprofit organizations working to end Alzheimer's disease, took a $100,000 prize, out of submissions from more than 280 partnering organizations to the Sanofi US's Partners in Patient Health Collaborate | Activate Innovation Challenge.
The U.S. Food and Drug Administration (FDA) on November 18 approved the new drug application for aflibercept ophthalmic solution (trade name EYLEA), a new product for treatment of wet age-related macular degeneration (wet AMD). The action follows the unanimous recommendation of the drug's approval, issued last June by the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee.
The American Health Assistance Foundation, a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.